Stem Cell Research (Mar 2022)

Establishment of a human induced pluripotent stem cell line (CSUASOi008-A) from a type 2 diabetic patient with retinopathy

  • Feng Tan,
  • Chengcheng Ding,
  • Xihao Sun,
  • Yini Wang,
  • Yu Peng,
  • Yuqin Liang,
  • Zhongping Chen,
  • Shibo Tang,
  • Jiansu Chen

DOI
https://doi.org/10.1016/j.scr.2021.102637
Journal volume & issue
Vol. 59
p. 102637

Abstract

Read online

Diabetic retinopathy (DR) is one of the most common and severe microvascular complications of diabetes, and the leading cause of preventable blindness in working-aged people. Here, we generated an induced pluripotent stem (iPS) cell line using blood-derived cells from a patient with DR. Peripheral blood mononuclear cells (PBMCs) were reprogrammed with Sendai virus.